Chart of the Day: Globus Medical (GMED)

NYSE: GMED | Globus Medical, Inc.  News, Ratings, and Charts

GMED – Possible breakdown looming for Globus Medical (GMED).

Over the past couple of  months, a ‘Head and Shoulders’ pattern has developed in the chart of Globus Medical Inc. (GMED - Get Rating).

GMED is a medical device company that develops products for patients with musculoskeletal disorders. Their products include implantable devices and surgical instruments used in orthopedic and spinal procedures. The company’s revenue and earnings have grown regularly over the past few years.

The company has also developed a robotic platform called ExcelsiusGPS. The platform employs big data to improve surgical precision. The platform is also expected to support augmented reality and artificial intelligence.

Like most stocks, GMED hit a 52-week low in March as the coronavirus pandemic spread throughout the world.  Since then, it’s been quite volatile – trending higher in April and May, and lower in June and July.

As you can see in the chart below, there is a level of support (red) that has formed at $44:

Chart of GMED provided by TradingView

The $44 support level is also the “neckline” for this head and shoulder pattern.  A head and shoulders pattern is a chart formation that technical analysts use to locate areas/prices at which increased momentum to the upside or downside should occur.

In this case, the first shoulder (blue) in GMED was in April/May, the head was in May/June, and the second shoulder is now forming in July.

If GMED breaks below the neckline/support level of $44, there is a good chance that we will see a breakdown in the stock.  Therefore, a trader could short GMED under $44 and expect to see momentum to the downside.

Have a good trading day!

Good luck!

Christian Tharp, CMT

Follow me on Twitter:  @cmtstockcoach

Stock Trading & Investing for Everyone

Want More Great Investing Ideas?

9 “BUY THE DIP” Growth Stocks for 2020

Top 5 WINNING Stock Chart Patterns

7 “Safe-Haven” Dividend Stocks for Turbulent Times


GMED shares were trading at $45.11 per share on Tuesday morning, down $0.28 (-0.62%). Year-to-date, GMED has declined -23.39%, versus a -1.79% rise in the benchmark S&P 500 index during the same period.


About the Author: christian


Christian is an expert stock market coach at the Adam Mesh Trading Group who has mentored more than 4,000 traders and investors. He is a professional technical analyst that is a certified Chartered Market Technician (CMT), which is a designation awarded by the CMT Association. Christian is also the author of the daily online newsletter Todays Big Stock. More...


More Resources for the Stocks in this Article

TickerPOWR RatingIndustry RankRank in Industry
GMEDGet RatingGet RatingGet Rating

Most Popular Stories on StockNews.com


Why Are Stocks Floating Higher?

Why are stocks breaking above 6,000 once again? When will they make news highs? And what is an investor to do now? Seasoned investor Steve Reitmeister shares his thoughts in this updated commentary.

How is the Stock Market Like a Helium Balloon?

Stocks have finally broke above 6,000 for the S&P 500 (SPY). The more important question is what comes next? Steve Reitmeister provides his answer in his latest market commentary.

Has the Bull Market Run Out of Steam?

It seems the S&P 500 (SPY) advance has stalled and cant crack above strong resistance at 6,000. Why is that happening? And what happens next? Read on for the answers...

Investors Remain “Cautiously Optimistic”

The S&P 500 (SPY) has made great advances since the lows of early April. Yet seem to be stuck under resistance at 6,000. What happens next depends on tariff talks. So let’s talk about the latest news on that front.

Bull Market Til Proven Otherwise

The phrase that paid for investors in 2025 was “Bull market til proven otherwise” Steve Reitmeister explains why in his latest market update and preview of top stock picks.

Read More Stories

More Globus Medical, Inc. (GMED) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All GMED News